Lenskart IPO and Groww IPO are attracting attention, with Lenskart concluding its subscription and Groww starting its process ...
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® Newly commissioned ...
Matica Biotechnology, Inc. ("Matica Bio"), a leading viral vector CDMO specializing in advanced therapies, today announced a ...
Nucelion Therapeutics Pvt Ltd, a wholly owned subsidiary of Bharat Biotech International Ltd, established a Contract Research Development and Manufacturing Organisation (CRDMO) focused on cell and ...
Hyderabad: Vaccine maker Bharat Biotech is foraying into the contract research development and manufacturing organisation (CRDMO) space with the setti.
Shardul Nautiyal, Mumbai Thursday, October 30, 2025, 08:00 Hrs [IST] ...
NurExone’s U.S. subsidiary, Exo-Top Inc., is advancing plans for the establishment of a GMP-compliant facility dedicated to naive exosome production. The Company believes participation in ARMI’s ...
White Oil Market Poised for Steady Growth, Projected to USD 3.16 billion by 2032 - Credence Research
The White Oil market is expanding steadily on the back of rising demand across pharmaceuticals, personal care, plastics and ...
Bharat Biotech launches Nucelion Therapeutics, a CRDMO in Hyderabad for advanced cell and gene therapy manufacturing and development.
1don MSN
Bharat Biotech forays into CRDMO space with new cell & gene therapies arm Nucelion Therapeutics
Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene ...
Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results